Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hirotaka Nakamura

Japan
Publications

Immunotherapy and Biomarker for Efficacy in Lymphoma

Immune Checkpoint Inhibitor (ICI), especially programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2 and the programmed cell-death protein 1 (PD-1) axis inhibitor, has become an essential part of treatment for patients with solid tumors, including melanoma, lung cancer and gastric cancer. As for hematological malignancies, ICI has also been introdu... Read More»

Hirotaka Nakamura and Nobuhiko Yamauchi

: Diagn Pathol Open 6: 179

10.4172/2476-2024.1000179

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top